![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028年までの北米ヒト肝臓モデル市場予測 - 新型コロナウイルス感染症の影響と地域分析(肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティングなど)、用途別(創薬、教育など) )、エンドユーザー(製薬企業、バイオテクノロジー企業、研究機関など)
TIPRE00026113 |
Pages: 98 |
Biotechnology |
Nov 2021
|
Type: Regional |
Status: Published
北米のヒト肝臓モデル市場は、2021年の98,522.08千米ドルから2028年までに2,08998.55千米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 11.3% の CAGR で成長すると推定されています。\\n\\n米国、カナダ、メキシコは北米の経済圏です。肝疾患の有病率の上昇により、北米のヒト肝臓モデル市場の成長が促進されると予想されます。肝臓は身体最大の内臓であり、500 以上の機能を果たします。肝臓はほとんどの生体異物化合物およびその生理活性代謝物に曝露されており、化学的に誘発される肝疾患を起こしやすいため、肝臓毒性はリスク評価における主要な懸念事項です。 C 型肝炎ウイルス (HCV)、慢性 B 型肝炎ウイルス (HBV)、非アルコール性脂肪肝疾患 (NAFLD)、およびアルコール関連肝疾患 (ALD) は、慢性肝疾患の主な原因の 1 つです。ウイルス性肝炎は引き続き肝不全による主な死亡原因となっており、同時に NAFLD は肝臓罹患率とそれに関連する死亡率の最も急速に増加している要因の 1 つとなっています。 NAFLD や慢性肝炎感染症などの慢性肝疾患は、原発性肝がん「肝細胞がん (HCC)」のリスク上昇と関連しています。肝硬変はよく知られており、HCC の主な原因であり、発生率は約 50 万人、発症率は 50 万人です。 ~年生存率は 10%。最近の推定によると、このがんの発生率は驚くべき速度で増加しており、HCC は男性では 5 番目に多いがん、女性では 7 番目に多いがんとなっています。HCC は、~に寄与している可能性があります。肝臓がんの他の種類には、肝がんの悪性疾患である胆管細胞がん(CCC)があります。肝胆管、肝芽腫。肝芽腫は、小児における最も一般的な肝臓の悪性腫瘍です。したがって、慢性および急性の疾患や微生物感染を含む肝疾患の有病率の上昇により、北米地域全体で肝臓モデルの需要が増加しています。 \\n\\n疾病管理予防センター (CDC) によると、慢性肝疾患を患っている患者や免疫力が低下している患者は、新型コロナウイルス感染症による重篤な病気になるリスクが高くなります。米国で報告された新型コロナウイルス感染症(COVID-19)症例の急増により、全米の医療行為に広範な変化が必要となった。臓器移植は医療上の緊急事態であることが多いですが、病院リソースの需要と使用の増大により、移植センターがこれらの救命処置を行う能力に悪影響を及ぼしています。新型コロナウイルス感染症関連の問題により、この地域での肝移植が妨げられており、予想される期間にわたりヒト肝臓モデル市場への脅威となっている。 \\n\\n新しい機能とテクノロジーを使用することで、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因は、北米のヒト肝臓モデル市場を牽引する可能性があります。北米のヒト肝臓モデル市場は、予測期間中に良好なCAGRで成長すると予想されます。 \\n\\n北米ヒト肝臓モデル市場の収益と 2028 年までの予測 (千米ドル) \\n\\n北米ヒト肝臓モデル市場セグメンテーション \\n北米ヒト肝臓モデル市場のタイプ別\\n- 肝臓オルガノイド\\n- 肝臓オン- a-チップ\\n- 2D モデル\\n- 3D バイオプリンティング\\n- その他\\n用途別北米ヒト肝臓モデル市場\\n- 創薬\\n- 教育\\n- その他\\nエンド ユーザー別北米ヒト肝臓モデル市場\\ n- 製薬およびバイオテクノロジー企業\\n- 研究機関 \\n- その他 \\n北米ヒト肝臓モデル市場、国別\\n- 米国 \\n- カナダ \\n- メキシコ \\n北米ヒト肝臓モデル市場 -言及された企業 \\n- BioIVT\\n- CELLINK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- ORGANOVO HOLDINGS INC.\\n- THERMO FISHER SCIENTIFIC INC.\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. BioIVT
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America human liver models market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America human liver models market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Related Reports
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000